A new regimen for heparin use in acute coronary syndromes. Am Heart J 1999;138:313-8.Hochman JS, Wali AU, Gavrila D et al (1999) A new regimen for heparin use in acute coronary syndromes. Am Heart J 138(2 Pt 1):313–318
Acute coronary syndrome (ACS) is sudden decreased blood flow to your heart. This causes a lack of oxygen to your heart and can lead to unstable angina or a heart attack.DISCHARGE INSTRUCTIONS:Call your local emergency number (911 in the US) for any of the following:You have any of the ...
Acute coronary syndrome (ACS) is sudden decreased blood flow to your heart. This causes a lack of oxygen to your heart and can lead to unstable angina or a heart attack.DISCHARGE INSTRUCTIONS:Call your local emergency number (911 in the US) for any of the following:You have any of the ...
ImpaCt of aspirin regimen on THrombin generation in diabEtic patients with acute coronary syndrome: CARTHaGE-ACS trialAspirinThrombin generationDiabetesAcute coronary syndromeBackground Diabetes is associated with a high rate of events after acute coronary syndrome. It was recently reported that once-daily...
et al. Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy—design and rationale of the Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 trial. J. Cardiovasc. Transl. Res....
ACS indicates acute coronary syndrome. Figure 2. Cumulative Incidence of the Primary End Point and Safety End Point at 1 Year View LargeDownload The Kaplan-Meier curves show the cumulative incidence of the primary composite end point (all-cause mortality, myocardial infarction [MI], or st...
Nissen, MD JAMA Abstract Context Limited data are available evaluating how the timing and intensity of statin therapy following an acute coronary syndrome (ACS) event affect clinical outcome. Objective To compare early initiation of an intensive statin regimen with delayed initiation of a less ...
Rivaroxaban, a new oral factor Xa inhibitor, has been tried for this indication in the 'Anti-Xa Therapy to Lower Cardiovascular Events in Addition to Standard Therapy in Subjects With Acute Coronary Syndrome ACS 2-Thrombolysis In Myocardial Infarction 51' (ATLAS ACS 2-TIMI 51) trial using a ...
Enoxaparin and glycoprotein IIb/IIIa inhibition in non–ST-elevation acute coronary syndrome: Insights from the INTERACT trial Unfractionated heparin (UFH) has been considered the standard anticoagulant for patients with non–ST-segment-elevation acute coronary syndromes (NSTE ACS)... S Goodman - 《Am...
acute coronary syndrome 點擊卡片即可翻轉 👆 prolonged ischemia to cardiac cells leads to permanent damage occurs after 20 minutes of hypoxia, restore blood flow ASAP " time is muscle", degree of damage is displayed on ECG, ACS further defined as: unstable angina, NSTEMI, STEMI 點擊卡片即可翻轉...